# Indivior, Inc., North Chesterfield, VA – FDA Inspections

Source: https://www.keypedia.com/companies/indivior-inc/538f0c04-f1ec-40f4-8d9f-90ffbe8c75ab

> Inspection records and compliance data for Indivior, Inc. in North Chesterfield, Virginia. 7 FDA inspections on record, 1 Form 483, last inspected July 23, 2021.

---

## Details

- Name: Indivior, Inc.
- FEI Number: 3012118007
- Address Line 1: 10710 Midlothian Tpke Ste 125
- City: North Chesterfield
- State: Virginia
- Zip Code: 23235
- Country Name: United States
- Address: 10710 Midlothian Tpke Ste 125, North Chesterfield, Virginia 23235, United States
- Country: United States

## Related Documents

- FDA Inspection 1149155 - Indivior, Inc. - 2021-07-23 — classification: No Action Indicated (NAI), source: FDA, date: July 23, 2021
- FDA Inspection 1115618 - Indivior, Inc. - 2019-12-18 — classification: No Action Indicated (NAI), source: FDA, date: December 18, 2019
- FDA Inspection 1091880 - Indivior, Inc. - 2019-05-10 — classification: No Action Indicated (NAI), source: FDA, date: May 10, 2019
- [EIR - Indivior, Inc. - 2017-10-19](https://www.keypedia.com/records/eir/indivior-inc/e6bbda3f-b8b4-47d3-9035-4206b000f5c7) — source: FDA, date: October 19, 2017
- [483 - Indivior, Inc. - 2017-10-19](https://www.keypedia.com/records/483/indivior-inc/ef9dbf71-9783-4e50-bcd9-71a3826dafa7) — source: FDA, date: October 19, 2017
- [FDA Inspection 1030039 - Indivior, Inc. - 2017-10-19](https://www.keypedia.com/records/fda_inspections/indivior-inc/c7122a94-6dba-4c9e-ad56-6e3330aed84a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 19, 2017
- FDA Inspection 809099 - Indivior, Inc. - 2012-12-04 — classification: No Action Indicated (NAI), source: FDA, date: December 4, 2012
- FDA Inspection 809099 - Indivior, Inc. - 2012-12-04 — classification: No Action Indicated (NAI), source: FDA, date: December 4, 2012
- FDA Inspection 767415 - Indivior, Inc. - 2012-02-15 — classification: No Action Indicated (NAI), source: FDA, date: February 15, 2012
- FDA Inspection 767415 - Indivior, Inc. - 2012-02-15 — classification: No Action Indicated (NAI), source: FDA, date: February 15, 2012
- [FDA Inspection 580989 - Indivior, Inc. - 2009-05-08](https://www.keypedia.com/records/fda_inspections/indivior-inc/765add05-35b7-4316-ab04-f5e9ef2589b8) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 8, 2009

## Related Companies

- [Clario Inc](https://www.keypedia.com/companies/clario-inc/8f2d1f68-f3d8-4389-8100-efca010d9051)
- [Raptim Research Pvt. Ltd.](https://www.keypedia.com/companies/raptim-research-pvt-ltd/e9b524cf-a459-4a4d-9ac3-2198443949e2)
- [Douglas Glenn Young, M.D.](https://www.keypedia.com/companies/douglas-glenn-young-md/8df28cec-c379-4bbf-a055-6f2996fa1da3)
- [U.S. Army Medical Research Institute of Infectious Diseases](https://www.keypedia.com/companies/us-army-medical-research-institute-of-infectious-diseases/6d9547df-bbd2-48e8-ba75-d633d911af27)
- [Daniel J. DeAngelo, MD](https://www.keypedia.com/companies/daniel-j-deangelo-md/9a6d0cc8-13b8-4412-b0b4-933a9ef1352c)
- [Amryt Pharmaceuticals, Inc.](https://www.keypedia.com/companies/amryt-pharmaceuticals-inc/bfdef8ed-47d6-408f-a59b-16c2f17d796a)
- [Matrixx Initiatives, Inc.](https://www.keypedia.com/companies/matrixx-initiatives-inc/7fbc68ac-c0d4-4034-af19-6bd954d17e4d)
- [Ranbaxy Inc.](https://www.keypedia.com/companies/ranbaxy-inc/83cb62ce-f991-473a-a24b-f5951066c481)
- [Patheon Biologics (NJ) LLC](https://www.keypedia.com/companies/patheon-biologics-nj-llc/5d009aee-a952-4eee-a975-1b2bd0559e04)
- [Silliker Laboratories Group, Inc](https://www.keypedia.com/companies/silliker-laboratories-group-inc/a9d53aca-972c-488b-a699-d41cdadcf067)

## Related Officers

- [investigator](https://www.keypedia.com/people/courtney-n-long/32118415-bc77-4ac2-8f90-947e43cf10ff)
- [other](https://www.keypedia.com/people/kent-hoffman/083e2f25-ce22-4aa8-8ac7-32987018e5b0)
- [company_representative](https://www.keypedia.com/people/sunita-shinde/1a14e486-f325-45a5-84cc-c98f67251e57)